COMPANY MOLECULE PHARMACOLOGICAL GROUP COMPOSITION FORM REFERENCE

RGULATORY
AUTHORITY
PHARMEVO ERTUGLIFLOZIN L- EACH TAB CONTAINS 15 MG 5-D USFDA
PYROGLUTAMIC SGLT2 INHIBITORS
ACID
PHARMEVO SODIUM ION-EXCHANGE RESIN EACH SACHET CONTAINS 10 MG 5 USFDA
POLYSTYRENE
SULFONATE
PHARMEVO OMARIGLIPTIN DPP-4 INHIBITOR EACH TAB CONTAINS 12.5 MG 5-D PMDA JAPAN
PHARMEVO EDOXABAN (AS ANTI-COAGULANT EACH TAB CONTAINS 15 MG 5-D USFDA
TOSYLATE
MONOHYDRATE)
PHARMEVO ROFLUMILAST PHOSPHODIESTERASE INHIBITORS EACH TAB CONTAINS 250 MCG USFDA
PHARMEVO APREPITANT ANTI-EMETICS EACH CAP CONTAINS 125 MG 5 USFDA
PHARMEVO MEMANTINE ANTI-ALZHEIMER EACH CAP CONTAINS 14 MG 5-D USFDA
HYDROCHORIDE
HILTON 2-METHYL 2- LIVER TONIC EACH ML CONTAINS 100 MG 5
PHENOXY
PROPIONIC ACID
WILSON AZILSARTAN ANTI-HYPERTENSIVE 5-D
MEDOXOMIL (AS
POTASSIUM)
SEARLE LOPINAVIR+RITON ANTI-VIRAL EACH FILM COATED TABLET 5 USFDA
AVIR CONTAINS:
LOPINAVIR….…200MG
RITONAVIR.………50MG
BH CEFTAROLINE BETA-LACTAM ANTIBIOTIC EACH VIAL CONTAINS 600 MG 5-D USFDA
FOSAMIL
BH PLAZOMICIN AMINOGLYCOSIDE ANTIBIOTIC EACH 10 ML CONTAINS 500 MG 5-D USFDA
SULFATE
BH NITROGLYCERINE AGENTS FOR TREATMENT OF EACH GRAM OF CREAM CONTAINS 4 5-D USFDA
HEMORRHOIDS AND ANAL MG
FISSURES FOR TOPICAL
USE.
BH MIRABEGRON DRUGS FOR URINARY FREQUENCY EACH FILM-COATED EXTENDED 5 USFDA
AND INCONTINENCE. RELEASE TAB CONTAINS 25 MG
BH PERINDOPRIL ACE INHIBITORS, COMBINATION. EACH FILM COATED TABLET 5 HPRA
ARGININE+ CONTAINS: IRELAND
INDAPAMIDE+ PERINDOPRIL ARGININE …………5MG
AMLODIPINE INDAPAMIDE……………..1.25MG
AMLODIPINE ………………..…5MG